All In Biotech

Drug Trial Radar · NCT06329661

A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine

A Multi-center, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Corneal Endothelial Health of Dry Eye Disease Subjects Treated With Cyclosporine Ophthalmic Solution, 0.1%

Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 204 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

204

Actual

Start

Apr 22, 2024

Primary completion

Jul 30, 2025

Study completion Jul 30, 2025

Sponsor

Lead sponsor
Novaliq GmbHIndustry
Sponsor type
Industry
First posted
Mar 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this trial is to evaluate the effect of cyclosporine ophthalmic solution, 0.1% on corneal endothelial cell health in comparison to a hypotonic saline solution in subjects with Dry Eye Disease (DED)

Conditions

  • Dry Eye Disease
  • Endothelial Cell

Interventions

  • Cyclosporine ophthalmic solution, 0.1%Drug

    Colorless and clear opthalmic solution containing 0.1% Cyclosporine

  • Saline solution, 0.6%Drug

    Colorless and clear sodium chloride solution (0.6%)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Corneal Endothelial Cell Density (ECD)Time frame: 12 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • CYS-007 Investigational Site

    Newport Beach, California

  • CYS-007 Investigational Site

    Torrance, California

  • CYS-007 Investigational Site

    Garner, North Carolina

  • CYS-007 Investigational Site

    Shelby, North Carolina

  • CYS-007 Investigational Site

    Cranberry Township, Pennsylvania

  • CYS-007 Investigational Site

    Memphis, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.